Market revenue in 2023 | USD 552.2 million |
Market revenue in 2030 | USD 1,791.7 million |
Growth rate | 18.3% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 31.94% in 2023. Horizon Databook has segmented the Australia genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
The national network of research, Australian Genomics, is engaged in creating building blocks for the smooth and complete integration of genomic medicine in routine healthcare. This network is a collaboration of 80 hospitals, laboratories that perform genetic testing, research institutes, and data management services.
Australian Genomics is adopting strategic initiatives to bridge the gap between the commercial implications of genomics and associated research activities. This robust research network is coupled with the advent of new genetic testing technologies, which is further driving the demand for cancer treatments, gene therapies, and personalized medicine developed based on individual genetic makeup.
In December 2021, the Australian Federal Police announced using massively parallel sequencing or NGS technology to predict traits of criminals from the DNA collected from crime scenes. This would allow investigators to predict biogeographical ancestry, gender, eye color, and hair color. The potential application of NGS in forensic research is expected to further boost the demand for NGS in the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia genomics market , including forecasts for subscribers. This country databook contains high-level insights into Australia genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account